MedPath
HSA Approval

PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION

SIN08899P

PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION

PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION

September 4, 1996

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Regulatory Information

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Therapeutic

Prescription Only

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

A12CX

其它矿物质药物

Manufacturer Information

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI NORGE AS

Active Ingredients

POTASSIUM IODIDE

1.31 mcg/ml

Potassium Iodide

SODIUM FLUORIDE

126 mcg/ml

Sodium fluoride

COPPER CHLORIDE DIHYDRATE

53.7 mcg/ml

MANGANESE CHLORIDE TETRAHYDRATE

3.6 mcg/ml

Manganese

ZINC CHLORIDE

521 mcg/ml

Zinc chloride

SODIUM SELENITE ANHYDROUS

4.38 mcg/ml

Selenious acid
© Copyright 2025. All Rights Reserved by MedPath
PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION - HSA Approval | MedPath